C-Mer Eye Care Holdings (HKSE:03309) Interest Expense : HK$-18 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is C-Mer Eye Care Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. C-Mer Eye Care Holdings's interest expense for the six months ended in Dec. 2023 was HK$ -9 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-18 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. C-Mer Eye Care Holdings's Operating Income for the six months ended in Dec. 2023 was HK$ 66 Mil. C-Mer Eye Care Holdings's Interest Expense for the six months ended in Dec. 2023 was HK$ -9 Mil. C-Mer Eye Care Holdings's Interest Coverage for the quarter that ended in Dec. 2023 was 7.48. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

C-Mer Eye Care Holdings Interest Expense Historical Data

The historical data trend for C-Mer Eye Care Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Mer Eye Care Holdings Interest Expense Chart

C-Mer Eye Care Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-7.53

-10.35

-13.00

-19.66

-18.12

C-Mer Eye Care Holdings Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial													-6.85	-9.69	-9.97	-9.27	-8.85

C-Mer Eye Care Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-18 Mil.

C-Mer Eye Care Holdings (HKSE:03309) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

C-Mer Eye Care Holdings's Interest Expense for the six months ended in Dec. 2023 was HK$-9 Mil. Its Operating Income for the six months ended in Dec. 2023 was HK$66 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was HK$246 Mil.

C-Mer Eye Care Holdings's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	66.225	/	-8.854
	=	7.48

The higher the ratio, the stronger the company's financial strength is.

C-Mer Eye Care Holdings (HKSE:03309) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-Mer Eye Care Holdings Ltd (HKSE:03309) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-3 Pedder Street, Suite 1335, Central Building, Central, Hong Kong, HKG

Website

https://www.cmereye.com

C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include Sales of medical consumables, Mainland China ophthalmic business and Mainland China dental business. It generates a vast majority of its revenue from the provision of the ophthalmic services segment.

Executives

C-mer Group Limited	2101 Beneficial owner
Lam Shun Chiu Dennis	2201 Interest of corporation controlled by you
Li Xiaoting	2201 Interest of corporation controlled by you

C-Mer Eye Care Holdings (HKSE:03309) Headlines

No Headlines